Related Experiment Videos
Modulation of oncogene expression by epidermal growth factor and gamma-interferon in A431 squamous carcinoma cells
1Uniformed Services University of the Health Sciences, Department of Pathology, Bethesda, MD.
Abstract:
Epidermal growth factor (EGF) acts, in a dose dependent manner, as both a mitogen and an inhibitor of growth of the A431 squamous carcinoma cell line. gamma-interferon (IFN) also inhibits A431 cell growth. The dual effects of EGF on A431 growth and expression of the oncogenes, EGF receptor (EGFR) and Ha-ras, were evaluated with or without gamma-IFN. A mitogenic level (10pM) of EGF had no effect on expression of EGFR 10 kb mRNA or protein. gamma-IFN combined with 10pM EGF caused an initial drop in EGFR mRNA not reflected at the protein level; at 72 hours, the level of EGFR 10kb mRNA rose and inhibition of cell growth was observed. Treatment with a cytostatic amount (10nM) of EGF resulted in decreased expression of EGFR 10kb mRNA and protein within 24 hours; combined treatment with gamma-IFN caused rapid cell death. Expression of Ha-ras mRNA paralleled that of EGFR mRNA upon treatment with 10pM EGF and/or gamma-IFN, but differed with 10nM EGF.
Insights
Epidermal growth factor (EGF) and gamma-interferon (IFN) differentially affect A431 cancer cell growth. Combining EGF with IFN can lead to cell death or growth inhibition, impacting EGF receptor (EGFR) and Ha-ras oncogene expression.
Area of Science:
- Oncology
- Molecular Biology
- Cell Biology
Background:
- Epidermal growth factor (EGF) exhibits dose-dependent mitogenic and inhibitory effects on A431 squamous carcinoma cells.
- Gamma-interferon (IFN) is also known to inhibit the growth of A431 cells.
- The interplay between EGF, IFN, and oncogene expression in cancer cells requires further investigation.
Purpose of the Study:
- To investigate the combined effects of EGF and IFN on A431 cell growth.
- To analyze the impact of EGF and IFN on the expression of epidermal growth factor receptor (EGFR) and Ha-ras oncogenes.
- To elucidate the dose-dependent responses of A431 cells to EGF and IFN treatments.
Main Methods:
- Treatment of A431 cells with varying concentrations of EGF (10pM and 10nM) and gamma-IFN.
- Evaluation of cell growth inhibition and cell death.
- Quantitative analysis of EGFR and Ha-ras mRNA and protein expression levels at different time points.
Main Results:
- A mitogenic concentration of EGF (10pM) did not affect EGFR mRNA or protein levels, but its combination with IFN initially decreased EGFR mRNA, followed by an increase and growth inhibition at 72 hours.
- A cytostatic concentration of EGF (10nM) decreased EGFR mRNA and protein within 24 hours; combined with IFN, it induced rapid cell death.
- Ha-ras mRNA expression generally paralleled EGFR mRNA expression, with notable differences observed under 10nM EGF treatment.
Conclusions:
- EGF and IFN exert complex, dose-dependent effects on A431 cell proliferation and oncogene expression.
- The combination of EGF and IFN can lead to significant growth inhibition or cell death, mediated by alterations in EGFR and Ha-ras expression.
- These findings highlight the potential of targeting EGF and IFN pathways for cancer therapy.